Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Oxygen saturation, Pain, Pulmonary fibrosis, Rhinitis allergic
Clinical narrative: Carpal tunnel syndrome; Tendon rupture; nasal stuffiness/runny nose; Pain; Nasal allergy; Asthma; Inflammation; COVID-19 virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), COVID-19 (COVID-19 virus test positive), CARPAL TUNNEL SYNDROME (Carpal tunnel syndrome), TENDON RUPTURE (Tendon rupture) and NASAL CONGESTION (nasal stuffiness/runny nose) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis aggravated.    The patient's past medical history included Bronchitis on 20-Jan-2020, COVID-19 from 25-Dec-2019 to 05-Jan-2020 and Tendon operation (it as a procedure for the torn tendons). Concurrent medical conditions included Bronchial pneumonia (sore throat/bronchitis turned into pneumonia) since 20-Jan-2020 and Rheumatoid arthritis.   On 15-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and dose of ADALIMUMAB (HUMIRA) (Subcutaneous) Solution for injection in pre-filled pen. On 15-Jan-2022, the patient experienced COVID-19 (COVID-19 virus test positive). On 14-Feb-2022, the patient experienced INFLAMMATION (Inflammation). On an unknown date, the patient experienced PAIN (Pain), CARPAL TUNNEL SYNDROME (Carpal tunnel syndrome), TENDON RUPTURE (Tendon rupture), NASAL CONGESTION (nasal stuffiness/runny nose), RHINITIS ALLERGIC (Nasal allergy) and ASTHMA (Asthma). On 03-Feb-2022, COVID-19 (COVID-19 virus test positive) had resolved. At the time of the report, PAIN (Pain) was resolving and CARPAL TUNNEL SYNDROME (Carpal tunnel syndrome), TENDON RUPTURE (Tendon rupture), NASAL CONGESTION (nasal stuffiness/runny nose), INFLAMMATION (Inflammation), RHINITIS ALLERGIC (Nasal allergy) and ASTHMA (Asthma) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2022, SARS-CoV-2 test: (Positive) Positive. On an unknown date, Imaging procedure: Pulmonary Fibrosis. On an unknown date, Oxygen saturation: 95 to 97 percent. On an unknown date, Pulmonary fibrosis: 80 to 85 percent.         Scale for Pain levels was reported from 5 out of 6 to a 2 out of 3.   The event of tendon in elbow was amended to surgery on tendon of elbow and shoulder.  Dose description was reported as Humira as Solution for injection in pre-filled pen  No concomitant medications were reported.  On 14 Feb 2022 patient had tendon surgery for severed tendon in elbow. He stated that Humira might had possible to reduced his pain levels. He stated the day prior to tested positive for Covid 19 right after he was given  the moderna booster similar to allergies nose running and stuffy. He had carpool tunnel in both wrists, torn  tendons, hands and asthma. He also had sore throat, bronchitis which was turned into pneumonia which took he  allergy shots, 95 to 97 percent of oxygen. Also had scar on lungs 80 to 85 percent. He did test positive for  COVID 19 possibly from younger daughter.  The reporter's causality for the event(s) of surgery on tendon of elbow and shoulder, scar on lungs, carpal tunnel in both wrists/torn tendons hands, carpal tunnel in both wrists/torn tendons/hands unknown onset, nose running stuffy after allergies nose running stuffy asthma and pain was not provided. the reporter's causality for the event(s) of COVID19 positive, inflammation, COVID 19 and sore throat/bronchitis turned into pneumonia onset 20 Jan 2020 with humira(adalimumab) was no reasonable possibility.  No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in   Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2022: Follow up document contain event information updated.  Company comment:  This is a spontaneous case concerning a 45-year-old male patient with no relevant medical history, who experienced the unexpected, non-serious adverse event of special interest of COVID-19. The patient tested positive for COVID-19 1 week after receiving the booster/third dose of mRNA-1273 vaccine. The COVID-19 resolved after 12 days. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 45-year-old male patient with no relevant medical history, who experienced the unexpected, non-serious adverse event of special interest of COVID-19. The patient tested positive for COVID-19 1 week after receiving the booster/third dose of mRNA-1273 vaccine. The COVID-19 resolved after 12 days. The benefit-risk relationship of mRNA-1273 is not affected by this report.